# Mavyret

NDC: 0074-2600
Generic name: Glecaprevir and Pibrentasvir
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: PELLET
Routes: ORAL
Marketing started: 20210610

FDA application: NDA215110

## Active ingredients

- GLECAPREVIR: 50 mg/1
- PIBRENTASVIR: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-2600"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-2600
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7bf99777-0401-9095-8645-16c6e907fcc0